Overview of Silomat
Defining Silomat: Classification and Composition
Silomat is a medication with the active ingredient Clobutinol hydrochloride. It is classified as a synthetic non-opioid antitussive agent, a category of medicine used to suppress the involuntary cough reflex. This compound functions as a cough suppressant, meaning its primary purpose is to reduce the frequency and intensity of coughing through its action on the nervous system.
The compound, Clobutinol, is chemically defined as a piperidine derivative, which characterizes its nature as a synthetically developed compound. This classification distinguishes its action on the cough reflex as occurring through non-narcotic pathways, separating it structurally from opioid-based antitussives. Silomat is typically presented as a single active ingredient product, formulated with a base vehicle such as an aqueous or non-alcoholic syrup or a fatty base for suppositories.
Physical Forms and General Therapeutic Purpose
Clobutinol is prepared in various dosage forms, including oral syrup, drops, and coated tablets, as well as suppositories. These allow for delivery via the oral and rectal routes of administration. This variety in form provides options for different patient needs, such as those who have difficulty swallowing tablets or require alternative absorption profiles.
Its general purpose is to provide symptomatic relief from a dry, unproductive cough, which is the type of cough often associated with irritation during acute respiratory tract infections. Clobutinol’s mechanism involves a central action on the brain's cough center, which raises the threshold at which the involuntary reflex occurs. This action addresses the neurological urge to cough, providing relief in situations where a persistent cough may be interrupting rest.
